The purpose of this study is to identify within a cohort of ICU patients admitted for severe illness those who are at risk of death in the year following the discharge from ICU.
FROG-ICU is an epidemiological, observational, prospective, multi centric, cohort study designed for description, prognostic and evaluation. This trial includes as a first step a complete registry of patients admitted to the ICU and as a second step, the outcome of the patients at 1 year after they have been discharged alive from ICU. Plasma and urine samples will be with drawn biomarkers measurements at admission and ICU discharge. It is a multicentric study involving 1 center in Belgium et 24 centers in France.
Study Type
OBSERVATIONAL
Enrollment
2,137
Department of Anesthesiology and Intensive Care Unit - Lariboisiere Hospital
Paris, France
St Louis hospital, department of intensive care
Paris, France
All cause mortality at one year after ICU discharge
Time frame: one year
To assess quality of life in the year following a stay in ICU
Time frame: one year
To identify key determinants of cardiovascular morbidity and mortality in the year following a stay in ICU
Time frame: one year
To investigate the performance of plasma biomarkers usually measured in ICU, to assess the risk of death during the stay in ICU and one year after the discharge.
Time frame: one year
To set up a biological collection of plasma and urine, in order to measure new plasma biomarkers in the assessment of prognosis in the year following a stay in ICU.
Time frame: one year
to evaluate social conditions
Time frame: one year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.